Evidence map›Paper›PMID 39607981›Full record

ArticleGigaScience2024

demuxSNP: supervised demultiplexing single-cell RNA sequencing using cell hashing and SNPs.

Michael P Lynch, Yufei Wang, Shannan Ho Sui, Laurent Gatto, Aedin C Culhane

Abstract read
In one paragraph

Article in GigaScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael P LynchSchool of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute (HRI), University of Limerick, Limerick V94 T9PX, Ireland.ORCID 0000-0001-9535-6461
Yufei WangDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0000-0002-2573-0611
Shannan Ho SuiHarvard T.H. Chan School of Public Health, Boston, MA 02215, USA.ORCID 0000-0002-6191-4709
Laurent GattoComputational Biology and Bioinformatics Unit (CBIO), de Duve Institute, Université catholique de Louvain, Brussels 1200, Belgium.ORCID 0000-0002-1520-2268
Aedin C CulhaneSchool of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute (HRI), University of Limerick, Limerick V94 T9PX, Ireland.ORCID 0000-0002-1395-9734

Funding

Chan Zuckerberg Initiative DAF CZF 2019-002,443FY21 Idea Development Award W81XWH-21-1-0482FY21 Translational Research Partnership Award W81XWH-21-1-0442Kidney Cancer Association Trailblazer AwardKidney Cancer Research ProgramSchool of MedicineSilicon Valley Community FoundationUniversity of LimerickU.S. Department of DefenseWong Family Award
6 · The paper itself

Abstract

backgroundMultiplexing single-cell RNA sequencing experiments reduces sequencing cost and facilitates larger-scale studies. However, factors such as cell hashing quality and class size imbalance impact demultiplexing algorithm performance, reducing cost-effectiveness.

findingsWe propose a supervised algorithm, demuxSNP, which leverages both cell hashing and genetic variation between individuals (single-nucletotide polymorphisms [SNPs]). demuxSNP addresses fundamental limitations in demultiplexing methods that use only one data modality. Some cells may be confidently demultiplexed using probabilistic hashing methods. demuxSNP uses these data to infer the genotype of singlet and doublet clusters and predict on cells assigned as negative, uncertain, or doublet using a nearest-neighbor approach adapted for missing data.We benchmarked demuxSNP against hashing, genotype-free SNP and hybrid methods on simulated and real data from renal cell cancer. demuxSNP outperformed standalone hashing methods on low-quality hashing data benchmark, improved overall classification accuracy, and allowed more high RNA quality cells to be recovered. Through varying simulated doublet rates, we showed that genotype-free SNP and hybrid methods that leverage them were impacted by class size imbalance and doublet rate. demuxSNP's supervised approach was more robust to doublet rate in experiments with class size imbalance.

conclusionsdemuxSNP uses hashing and SNP data to demultiplex datasets with low hashing quality where biological samples are genetically distinct. Unassigned or negative cells with high RNA quality are recovered, making more cells available for analysis. Data simulation and benchmarking pipelines as well as processed benchmarking data for 5-50% doublets are publicly available. demuxSNP is available as an R/Bioconductor package (https://doi.org/doi:10.18129/B9.bioc.demuxSNP).

Indexed as

AlgorithmsPolymorphism, Single NucleotideSequence Analysis, RNASingle-Cell AnalysisComputational BiologyHumansKidney NeoplasmsSoftwarecell hashingdemultiplexingsingle-cellSNPs

Identifiers

PMID39607981
PMCPMC11604057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.